Foreign Institutional Investors (FIIs) play a crucial role in shaping market sentiment and influencing stock performance in India. Despite a majority of stocks seeing FII exits in the past few quarters, below is the list of Stocks where FIIs have consistently increased their stake over the past three quarters, often signalling strong fundamentals and long-term growth potential. This trend can indicate rising confidence in a company’s performance and outlook.
Wipro Ltd
Wipro Limited is a leading Indian multinational corporation that provides information technology, consulting, and business process services. Headquartered in Bengaluru, Wipro operates in over 60 countries and serves a diverse range of industries, including financial services, healthcare, manufacturing, retail, and telecommunications. Established in 1945, the company transitioned from a consumer goods business to an IT services giant and is known for its focus on innovation, digital transformation, and sustainability.
Foreign Institutional Investors have steadily increased their stake in Wipro Ltd over the past three consecutive quarters of FY25. FII holding rose from 7.27 Percent in Q2 to 7.81 percent in Q3, and further to 8.35 percent by the end of Q4.
Bharat Electronics Ltd
Bharat Electronics Limited is a Navratna Public Sector Undertaking under the Ministry of Defence, Government of India. Established in 1954, BEL specializes in the design, development, and manufacture of advanced electronic products and systems for the Indian Armed Forces. The company has expanded its portfolio to include non-defence sectors such as homeland security, smart cities, e-governance, and renewable energy solutions.
Foreign Institutional Investors have steadily increased their stake in Bharat Electronics Ltd over the past three consecutive quarters of FY25. FII holding rose from 17.27 Percent in Q2 to 17.34 percent in Q3, and further to 17.55 percent by the end of Q4.
Divis Laboratories Ltd
Divi’s Laboratories Limited is a leading Indian multinational pharmaceutical company specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. Established in 1990 and headquartered in Hyderabad, Telangana, Divi’s operates two state-of-the-art manufacturing facilities in Telangana and Andhra Pradesh. The company offers a diverse product portfolio, including generic APIs, nutraceutical ingredients, and custom synthesis services for major global pharmaceutical companies
Foreign Institutional Investors have steadily increased their stake in Divi’s Laboratories Limited over the past three consecutive quarters of FY25. FII holding rose from 17.25 Percent in Q2 to 17.98 percent in Q3, and further to 18.01 percent by the end of Q4.
Macrotech Developers Ltd
Macrotech Developers Ltd, formerly known as Lodha Developers, is one of India’s leading real estate companies, headquartered in Mumbai. Established in 1980, the company is engaged in the development of residential, commercial, and industrial real estate projects across key Indian cities like Mumbai, Pune, and Hyderabad, as well as internationally in London. Known for landmark projects such as The World Towers and Palava City, Macrotech focuses on delivering premium and affordable housing while emphasizing sustainable and smart city development.
Foreign Institutional Investors have steadily increased their stake in Macrotech Developers Ltd over the past three consecutive quarters of FY25. FII holding rose from 24.20 Percent in Q2 to 24.45 percent in Q3, and further to 24.64 percent by the end of Q4.
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd is a leading Indian pharmaceutical company headquartered in Ahmedabad, Gujarat. Founded in 1959, the company specializes in branded generic formulations and has a strong presence in key therapeutic areas such as cardiovascular, central nervous system, gastro-intestinal, and diabetology. Torrent operates globally in over 50 countries, with robust R&D capabilities and USFDA-approved manufacturing facilities, making it a key player in the global pharma industry.
Foreign Institutional Investors have steadily increased their stake in Torrent Pharmaceuticals Ltd over the past three consecutive quarters of FY25. FII holding rose from 14.46 Percent in Q2 to 16.17 percent in Q3, and further to 16.31 percent by the end of Q4.
Written By Likesh Babu S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
